BiomedParse, a revolutionary biomedical model, unifies image segmentation, detection, and recognition across nine modalities, outperforming traditional methods and enabling scalable, precise analysis of complex biomedical images.
PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics – Psychedelic Alpha
TORONTO, July 18, 2023 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a commercial-focused specialty pharmaceutical company, is pleased